Centene Corporation (CNC)
NYSEHealth CareHealthcare PlansSnapshot 2026-07-08
$66.12+0.11%
Close 2026-07-07 · 1-day change
Reading CNC? This analysis is rebuilt every market day. Get it tracked free. No credit card.
Track CNC free→NYSEHealth CareHealthcare PlansSnapshot 2026-07-08
Reading CNC? This analysis is rebuilt every market day. Get it tracked free. No credit card.
Track CNC free→Daily closes. Earnings/event dots are placed inline.
Industries move in repeating boom-and-bust cycles. This shows where this stock’s industry sits in that cycle, stage by stage (recovery → expansion → supercycle → steady → deceleration → contraction), from its fundamentals (orders, revenue, capital spending), not the stock’s price.
A booming industry is a tailwind for the names in it; a contracting one is a headwind. Companies in the same industry tend to rise and fall together with the cycle, the way a tide lifts and lowers every boat in the harbor at once, so a large part of a stock’s swing can come from where its industry sits rather than from the company itself. It’s context for reading the company’s results, not a buy/sell call. Full explanation →
Health Care is in steady. Describes the industry's cycle state, not a call on this stock.
The stage band shows the industry’s cycle over the chart’s timeline (each color a stage); a ▼ marks a quarter its growth inflected down — amber is an unconfirmed watch, red is confirmed the next quarter. Use “Overlay cycle on chart” to tint the price chart by stage. The industry’s fundamentals, not a signal on this stock.
Management is running behind on a stated commitment.
View ThesisRevenue growth is accelerating — up about 17% over the past year.
View GrowthMiddle-of-the-pack quality for its industry.
View QualityManagement screens weak on capital allocation, margins.
View ManagementExpectations look high — what the market is pricing in runs ahead of what analysts forecast.
View ValuationModerate volatility — typically moves about 2% a day.
View RiskCNC's growth depends on maintaining strong revenue despite recent membership declines. Revenue grew 5% year over year, and the last quarter beat expectations by 58%. It trades at 26× P/E, in line with its peer median. The market is pricing in more growth than expected, indicating full expectations. A specific risk is that guidance cuts could hurt credibility, with a 13% chance of missing next quarter. Peer multiples imply a price about 9% below where it trades. This read is provisional.
Trailing returns as of 2026-07-07. CNC is total return (includes dividends); the S&P 500 benchmark is price return (the index excludes dividends).
Based on 21 analysts currently covering CNC (as of Jul 2026).
Based on 12 Wall Street analysts offering 12-month price targets for CNC in the last 4 months.
A consensus fair price across 11 valuation methods, at three horizons. Current price $66.12. As of 2026-07-08. Estimates are diagnostics, not price targets. Short-horizon estimates are close to coin-flips, so confidence is a method-agreement read, not a prediction.
Today's peer multiple on trailing earnings, with no growth credited. This is the headline read.
Adds projected growth, so it leans optimistic by design. Read it as upside context, not a base case.
A price-focused, side-by-side fair-value read versus Managed Health Care — fair value, gap to price, and forward P/E.
Rate hikes could impact revenue growth and EPS guidance.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
End-of-day figures as of 2026-07-07. EPS is implied from price ÷ P/E. Not investment advice.
Current $66.12
The last 12 months of price, then the range of analyst 12-month targets from today’s $66.12.
Analyst ratings and price targets are third-party Wall Street estimates, not QuarterlyIQ’s view. Not investment advice.
A long-thesis check that carries the widest uncertainty of the three horizons.
Below average on quality vs scored peers
Direction of the business behind the multiple. Bands are backend reads; trailing-12-month basis.
Membership decline could hinder revenue growth objectives.
Threatens: Debt reduction by $1 billion in Q1 2026
Buyouts may hinder debt reduction efforts.